127 related articles for article (PubMed ID: 25696812)
21. The immunosuppressor st1959, a 3,5-diaryl-s-triazole derivative, inhibits T cell activation by reducing NFAT nuclear residency.
Lindstedt R; Ruggiero V; D' Alessio V; Manganello S; Petronzelli F; Stasi MA; Vendetti S; Assandri A; Carminati P; De Santis R
Int J Immunopathol Pharmacol; 2009; 22(1):29-42. PubMed ID: 19309550
[TBL] [Abstract][Full Text] [Related]
22. The Tpl-2 protooncoprotein activates the nuclear factor of activated T cells and induces interleukin 2 expression in T cell lines.
Tsatsanis C; Patriotis C; Bear SE; Tsichlis PN
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3827-32. PubMed ID: 9520452
[TBL] [Abstract][Full Text] [Related]
23. Age-related reductions in the activation of mitogen-activated protein kinases p44mapk/ERK1 and p42mapk/ERK2 in human T cells stimulated via ligation of the T cell receptor complex.
Whisler RL; Newhouse YG; Bagenstose SE
Cell Immunol; 1996 Mar; 168(2):201-10. PubMed ID: 8640866
[TBL] [Abstract][Full Text] [Related]
24. Multiple p21ras effector pathways regulate nuclear factor of activated T cells.
Genot E; Cleverley S; Henning S; Cantrell D
EMBO J; 1996 Aug; 15(15):3923-33. PubMed ID: 8670897
[TBL] [Abstract][Full Text] [Related]
25. Pseudoephedrine inhibits T-cell activation by targeting NF-κB, NFAT and AP-1 signaling pathways.
Fiebich BL; Collado JA; Stratz C; Valina C; Hochholzer W; Muñoz E; Bellido LM
Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):98-106. PubMed ID: 21631396
[TBL] [Abstract][Full Text] [Related]
26. Enhanced expression of DYRK1A in cardiomyocytes inhibits acute NFAT activation but does not prevent hypertrophy in vivo.
Grebe C; Klingebiel TM; Grau SP; Toischer K; Didié M; Jacobshagen C; Dullin C; Hasenfuss G; Seidler T
Cardiovasc Res; 2011 Jun; 90(3):521-8. PubMed ID: 21273244
[TBL] [Abstract][Full Text] [Related]
27. Binding and regulation of the transcription factor NFAT by the peptidyl prolyl cis-trans isomerase Pin1.
Liu W; Youn HD; Zhou XZ; Lu KP; Liu JO
FEBS Lett; 2001 May; 496(2-3):105-8. PubMed ID: 11356192
[TBL] [Abstract][Full Text] [Related]
28. Protein kinase Ctheta, a selective upstream regulator of JNK/SAPK and IL-2 promoter activation in Jurkat T cells.
Ghaffari-Tabrizi N; Bauer B; Villunger A; Baier-Bitterlich G; Altman A; Utermann G; Uberall F; Baier G
Eur J Immunol; 1999 Jan; 29(1):132-42. PubMed ID: 9933094
[TBL] [Abstract][Full Text] [Related]
29. Aromadendrin Inhibits T Cell Activation via Regulation of Calcium Influx and NFAT Activity.
Lee HS; Jeong GS
Molecules; 2020 Oct; 25(19):. PubMed ID: 33050076
[TBL] [Abstract][Full Text] [Related]
30. The Hsp90-specific inhibitor geldanamycin selectively disrupts kinase-mediated signaling events of T-lymphocyte activation.
Schnaider T; Somogyi J; Csermely P; Szamel M
Cell Stress Chaperones; 2000 Jan; 5(1):52-61. PubMed ID: 10701840
[TBL] [Abstract][Full Text] [Related]
31. T cell activation up-regulates the expression of the focal adhesion kinase Pyk2: opposing roles for the activation of protein kinase C and the increase in intracellular Ca2+.
Tsuchida M; Manthei ER; Alam T; Knechtle SJ; Hamawy MM
J Immunol; 1999 Dec; 163(12):6640-50. PubMed ID: 10586059
[TBL] [Abstract][Full Text] [Related]
32. CCR5 expression levels influence NFAT translocation, IL-2 production, and subsequent signaling events during T lymphocyte activation.
Camargo JF; Quinones MP; Mummidi S; Srinivas S; Gaitan AA; Begum K; Jimenez F; VanCompernolle S; Unutmaz D; Ahuja SS; Ahuja SK
J Immunol; 2009 Jan; 182(1):171-82. PubMed ID: 19109148
[TBL] [Abstract][Full Text] [Related]
33. Immunosuppressive activity of endovanilloids: N-arachidonoyl-dopamine inhibits activation of the NF-kappa B, NFAT, and activator protein 1 signaling pathways.
Sancho R; Macho A; de La Vega L; Calzado MA; Fiebich BL; Appendino G; Muñoz E
J Immunol; 2004 Feb; 172(4):2341-51. PubMed ID: 14764703
[TBL] [Abstract][Full Text] [Related]
34. The involvement of NFAT transcriptional activity suppression in SIRT1-mediated inhibition of COX-2 expression induced by PMA/Ionomycin.
Jia YY; Lu J; Huang Y; Liu G; Gao P; Wan YZ; Zhang R; Zhang ZQ; Yang RF; Tang X; Xu J; Wang X; Chen HZ; Liu DP
PLoS One; 2014; 9(5):e97999. PubMed ID: 24859347
[TBL] [Abstract][Full Text] [Related]
35. Human immunodeficiency virus type 1 Tat increases cooperation between AP-1 and NFAT transcription factors in T cells.
Hidalgo-Estévez AM; González E; Punzón C; Fresno M
J Gen Virol; 2006 Jun; 87(Pt 6):1603-1612. PubMed ID: 16690925
[TBL] [Abstract][Full Text] [Related]
36. Dephosphorylation of the nuclear factor of activated T cells (NFAT) transcription factor is regulated by an RNA-protein scaffold complex.
Sharma S; Findlay GM; Bandukwala HS; Oberdoerffer S; Baust B; Li Z; Schmidt V; Hogan PG; Sacks DB; Rao A
Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11381-6. PubMed ID: 21709260
[TBL] [Abstract][Full Text] [Related]
37. Nickel differentially regulates NFAT and NF-κB activation in T cell signaling.
Saito R; Hirakawa S; Ohara H; Yasuda M; Yamazaki T; Nishii S; Aiba S
Toxicol Appl Pharmacol; 2011 Aug; 254(3):245-55. PubMed ID: 21569788
[TBL] [Abstract][Full Text] [Related]
38. Prolonged high glucose suppresses phorbol 12-myristate 13-acetate and ionomycin-induced interleukin-2 mRNA expression in Jurkat cells.
Higai K; Tsukada M; Moriya Y; Azuma Y; Matsumoto K
Biochim Biophys Acta; 2009 Jan; 1790(1):8-15. PubMed ID: 18992303
[TBL] [Abstract][Full Text] [Related]
39. MiR-101 relates to chronic peripheral neuropathic pain through targeting KPNB1 and regulating NF-κB signaling.
Liu JC; Xue DF; Wang XQ; Ai DB; Qin PJ
Kaohsiung J Med Sci; 2019 Mar; 35(3):139-145. PubMed ID: 30887716
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of interleukin-2 production by CD4(+) T cells expressing TIM-3 through suppression of NFAT dephosphorylation and AP-1 transcription.
Lee MJ; Woo MY; Chwae YJ; Kwon MH; Kim K; Park S
Immunobiology; 2012 Oct; 217(10):986-95. PubMed ID: 22445722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
